Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 14
Submit an article Journal homepage
1,208
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version

Jiwon Yuna Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-6306-3944
ORCID Icon,
Jung-Ah Kima Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0001-6934-1987
ORCID Icon,
Junseo Parkc The Webb Schools, Claremont, CA, USA
,
Kyongok Imd Institute of Reproductive Medicine and Population Medical Research Center, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Young Eun Leea Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Dajeong Jeonga Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Sohee Ryua Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Kyu Min Limb Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Sung-Min Kimb Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
,
Yong-Oon Ahnb Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea;e Medical Research Center, Seoul National University, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0001-9904-9581
ORCID Icon &
Dong Soon Leea Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea;b Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected]
 show all
Pages 3498-3502 | Received 25 Apr 2020, Accepted 02 Aug 2020, Published online: 02 Sep 2020

References

  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Barbui T, Thiele J, Gisslinger H, et al. The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion. Blood Cancer J. 2018;8(2):15.
  • Gianelli U, Cattaneo D, Bossi A, et al. The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations. Mod Pathol. 2017;30(2):169–179.
  • Iurlo A, Gianelli U, Cattaneo D, et al. Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: comparison with the 2008 version. Am J Hematol. 2017;92(4):E48–E51.
  • Barbui T, Thiele J, Passamonti F, et al. Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. J Clin Oncol. 2011;29(23):3179–3184.
  • Thiele J, Kvasnicka HM, Mullauer L, et al. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood. 2011;117(21):5710–5718.
  • Rupoli S, Goteri G, Picardi P, et al. Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis. Diagn Pathol. 2015;10(1):29.
  • Jeryczynski G, Thiele J, Gisslinger B, et al. Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: the impact of minor clinical diagnostic criteria on the outcome of the disease. Am J Hematol. 2017;92(9):885–891.
  • Mudireddy M, Shah S, Lasho T, et al. Prefibrotic versus overtly fibrotic primary myelofibrosis: clinical, cytogenetic, molecular and prognostic comparisons. Br J Haematol. 2018;182(4):594–597.
  • Barosi G, Rosti V, Bonetti E, et al. Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis. PLoS One. 2012;7(4):e35631.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.